The effect of endotoxin administration on the pharmacokinetics of chlorzoxazone in humans

Clinical Pharmacology and Therapeutics

Volumn 66, Issue 6, 1999, Pages 554-562

  Poloyac, Samuel M ^b   Tosheva, Raina T ^b   Gardner, Brian M ^b   Shedlofsky, Steven I ^b   Blouin, Robert A ^a  

^a University of Kentucky   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHLORZOXAZONE; CYTOCHROME P450; DIMETHYLNITROSAMINE DEMETHYLASE; ENDOTOXIN; HEXOBARBITAL; LIPOPOLYSACCHARIDE; PHENAZONE; THEOPHYLLINE;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG HALF LIFE; DRUG METABOLISM; ENDOTOXEMIA; ENZYME INDUCTION; HUMAN; HUMAN EXPERIMENT; KIDNEY CLEARANCE; LIVER METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0142203148     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0009-9236(99)90062-0     Document Type: Article

References (42)

1. 1. Kushner I. Regulation of the acute phase response by cytokines and chemokines. Perspect Biol Med 1993;36: 611-22.
2. 2. Ghirnikar RS, Lee YL, Eng LF. Inflammation in traumatic brain injury: role of cytokines and chemokines. Neurochem Res 1998;23:329-40.
3. 3. Wolff SM, Kimball HR, Perry S, Root R, Kappas A. The biological properties of etiocholanolone. Ann Intern Med 1967;67:1268-95.
4. 4. Martich GD, Boujoukos AJ, Suffredini AF. Response of man to endotoxin. Immunobiology 1993;187:403-16.
5. 5. Alam T, An MR, Mifflin RC, Hsieh CC, Ge X, Papaconstantinou J. Trans-activation of the alpha 1-acid glycoprotein gene acute phase responsive element by multiple isoforms of C/EBP and glucocorticoid receptor. J Biol Chem 1993;268:15681-8.
6. 6. Navasa M, Gordon DA, Hariharan N, Jamil H, Shigenaga JK, Moser A et al. Regulation of microsomal triglyceride transfer protein mRNA expression by endotoxin and cytokines. J Lipid Res 1998;39:1220-30.
7. 7. Morgan ET. Regulation of cytochromes P450 during inflammation and infection. Drug Metab Rev 1997;29: 1129-88.
8. 8. Renton KW, Gray JD, Hall RI. Decreased elimination of theophylline after influenza vaccination. Can Med Assoc J 1980; 123:288-90.
9. 9. Renton KW, Mannering GJ. Depression of hepatic cytochrome P450 dependent monooxygenase systems with administered interferon inducing agents. Biochem Biophys Res Commun 1976;73:343-8.
10. 10. Sewer MB, Koop DR, Morgan ET. Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450. Drug Metab Dispos 1996;24:401-7.
11. 11. Sewer MB, Koop DR, Morgan ET. Differential inductive and suppressive effects of endotoxin and paniculate irritants on hepatic and renal cytochrome P-450 expression. J Pharmacol Exp Ther 1997;280:1445-54.
12. 12. Tindberg N, Baldwin HA, Cross AJ, Ingelman-Sundberg M. Induction of cytochrome P450 2E1 expression in rat and gerbil astrocytes by inflammatory factors and ischemic injury. Mol Pharmacol 1996;50:1065-72.
13. 13. Roe AL, Warren G, Hou G, Howard G, Shedlofsky SI, Blouin RA. The effect of high dose endotoxin on CYP3A2 expression in the rat. Pharm Res 1998;15:1603-8.
14. 14. Liao JS, Reiss WG. Drug-cytokine interactions: focus on cyclosporine. Pharmacotherapy 1996;16:401-8.
15. 15. Chen YL, LeVraux V, Leneveu A, Dreyfus F, Stheneur A, Florentin I, et al. Acute-phase response, interleukin-6, and alteration of cyclosporine pharmacokinetics. Clin Pharmacol Ther 1994;55:649-60.
16. 16. Morgan ET. Suppression of constitutive cytochrome P450 gene expression in livers of rats undergoing an acute phase response to endotoxin. Mol Pharmacol 1989;36: 699-707.
17. 17. Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, et al. Cytokines down-regulate expression of major cytochrome P450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 1993;44:707-15.
18. 18. Maheo K, Morel F, Antras-Ferry J, Langouet S, Desmots F, Corcos L, et al. Endotoxin suppresses the oltiprazmediated induction of major hepatic glutathione transferases and cytochromes P450 in the rat. Hepatology 1998;28:1655-62.
19. 19. Rockich KT, Blouin RA. The effect of the acute phase response on the pharmacokinetics of chlorzoxazone and CYP2E1 in vitro activity in rats. Drug Metab Dispos 1999;27:1074-7.
20. 20. Peter R, Bocker R, Beaune PH, Iwasaki M, Geungerich FP, Yang CS. Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem Res Toxicol 1990;3:566-73.
21. 21. Lucas D, Menez JF, Berthou F. Chlorzoxazone: an in vitro and in vivo substrate probe for liver CYP2E1. Methods Enzymol 1996;272:115-23.
22. 22. Yamazaki H, Guo Z, Geungerich FP. Selectivity of cytochrome P4502E1 in chlorzoxazone 6-hydroxylation. Drug Metab Dispos 1995;23:438-40.
23. 23. Schellens J, VanDerWart J, Danhof M, VanDerVelde E, Breimer D. Relationship between the metabolism of antipyrine, hexobarbitone, and theophylline in man as assessed by the cocktail approach. Br J Clin Pharmacol 1988;26:373-84.
24. 24. Shedlofsky SI, Israel BC, McClain CJ, Hill DB, Blouin RA. Endotoxin administration to humans inhibits cytochrome P450-mediated drug metabolism. J Clin Invest 1994;94:2204-14.
25. 25. Shedlofsky SI, Israel BC, Tosheva R, Blouin RA. Endotoxin depresses hepatic cytochrome P450-mediated drug metabolism in women. Br J Clin Pharmacol 1997; 43:627-32.
26. 26. Frye RF, Stiff DD. Determination of chlorzoxazone and 6-hydroxychIorzoxazone in human plasma and urine by high-performance liquid chromatography. J Chromatogr B Sci Biomed Appl 1996;686:291-6.
27. 27. Kwong TC. Free drug measurements: methodology and clinical significance. Clin Chim Acta 1985;153:193-216.
28. 28. Kaneko I, Takeuchi Y, Fukumori Y, Fukuda T. Effect of alpha-chloralose on disposition and pharmacological action of orally administered chlorzoxazone in rats. J Pharmacobiodyn 1991;14:429-34.
29. 29. Biro-Sauveur B, Eeckhoutte C, Sutra JF, Calleja C, Alvinerie M, Galtier P. Consequences of challenge infections with Fasciola hepatica on rat liver P450-dependent metabolism of sex hormones. J Steroid Biochem Mol Biol 1994;51:209-17.
30. 30. Kihara T, Toda A, Umesue I, Ono N, Shigematsu H, Soeda S, et al. Effect of interleukin 1 beta-induced fever on hepatic drug metabolism in rat. Xenobiotica 1998; 28:559-69.
31. 31. Kim RB, Wilkinson GR. CYP2E1 activity is not altered by influenza vaccination [letter]. Br J Clin Pharmacol 1996;42:529-30.
32. 32. DeVries JD, Salphati L, Horie S, Becker CE, Hoener BA. Variability in the disposition of chlorzoxazone. Biopharm Drug Dispos 1994;15:587-97.
33. 33. O'Shea D, Davis SN, Kim RB, Wilkinson GR. Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity. Clin Pharmacol Ther 1994;56:359-67.
34. 34. Girre C, Lucas D, Hispard E, Menez C, Dally S, Menez JF. Assessmant of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Biochem Pharmacol 1994;47:1503-8.
35. 35. Ullrich KJ. Specificity of transporters for "organic anions" and "organic cations" in the kidney. Biochim Biophys Acta 1994;1197:45-62.
36. 36. Roch-Ramel F. Renal transport of organic anions. Curr Opin Nephrol Hypertens 1998;7:517-24.
37. 37. Keppler D, Leier I, Jedlitschky G. Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol Chem 1997; 378:787-91.
38. 38. Vos TA, Hooiveld GJ, Koning H, Childs S, Meijer DK, Moshage H, et al. Up-regulation of the multidrug resistance genes, mrp1 and mdr1b, and down-regulation of the organic anion transporter, mrp2, and the bile salt transporter, spgp, in endotoxemic rat liver. Hepatology 1998; 28:1637-44.
39. 39. Churchill PC, Bidani AK, Schwanz MM. Renal effects of endotoxin in the male rat. Am J Physiol 1987;253(2 Pt 2):F244-50.
40. 40. Nadai M, Hasegawa T, Wang L, Haghgoo S, Nabeshima T, Kalo N. Time-dependent changes in the pharmacokinetics and renal excretion of xanthine derivative enprofylline induced by bacterial endotoxin in rats. Biol Pharm Bull 1995;18:1089-93.
41. 41. Nadai M, Hasegawa T, Kato K, Wang L, Nabeshima T, Kato N. The disposition and renal handling of enprofylline in endotoxemic rats by bacterial lipopolysaccharide (LPS). Drug Metab Dispos 1993;21:611-6.
42. 42. Nadai M, Hasegawa T, Kato K, Wang L, Nabeshima T, Kato N. Alterations in pharmacokinetics and protein binding behavior of cefazolin in endotoxemic rats. Antimicrob Agents Chemother 1993;37:1781-5.